To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition marks the close ...
Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...
A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...
In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: “10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...
NanoString, which has been acquired by Bruker, has won a victory in a patent battle with 10x Genomics. Billerica, MA-based Bruker said that the German Federal Patent Court has ruled in favor of ...
Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research Under the asset purchase agreement, Bruker has now acquired ...
* NANOSTRING TECHNOLOGIES-TO USE ABOUT $89.0 MILLION OF NET PROCEEDS TO PREPAY AMOUNTS BORROWED, FEES OWING RELATED TO TERMINATION OF SENIOR TERM LOAN FACILITY * NANOSTRING-TO USE ABOUT $89.0 MILLION ...
UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect Eric S. Whitaker, Chief Legal Officer for 10x Genomics, said, ...
Rick: I’m back after a pause in the newsletter last week following my biking accident. Thanks for your patience, everyone. I also received multiple kind notes from readers regarding my dislocated ...
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results